Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust Portfolio Holdings

Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust

  • $7.49 Billion
  • Q3 2024

Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust has filed its 13F form on October 21, 2024 for Q3 2024 where it was disclosed a total value porftolio of $7.49 Billion distributed in 22 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Amazon Com Inc with a value of $661M, Visa Inc. with a value of $660M, Apple Inc. with a value of $652M, Microsoft Corp with a value of $645M, and Berkshire Hathaway Inc with a value of $483M.

Examining the 13F form we can see an increase of $312M in the current position value, from $7.18B to 7.49B.

Below you can find more details about Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust portfolio as well as his latest detailed transactions.

Portfolio value $7.49 Billion
Technology: $2.87 Billion
Financial Services: $1.42 Billion
Communication Services: $1.03 Billion
Consumer Cyclical: $927 Million
Healthcare: $913 Million
Consumer Defensive: $340 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.06T
$661 Million 8.83% of portfolio
3,550,000
Q2 2024 Reduced 6.58%
$506B
$660 Million 8.81% of portfolio
2,400,000
Q4 2021 Added 43.71%
$3.62T
$652 Million 8.71% of portfolio
2,800,000
Q3 2023 Reduced 3.45%
$3.09T
$645 Million 8.62% of portfolio
1,500,000
Q2 2024 Reduced 11.76%
$424B
$483 Million 6.45% of portfolio
700
Q2 2024 Reduced 7.89%
$204B
$447 Million 5.97% of portfolio
500,000
Q1 2024 Reduced 12.66%
$60.6B
$428 Million 5.72% of portfolio
3,000,000
Q1 2024 Reduced 9.09%
$223B
$389 Million 5.19% of portfolio
1,100,000
Q2 2020 Added 307.41%
$234B
$373 Million 4.98% of portfolio
720,000
Q4 2023 Reduced 10.0%
$203B
$356 Million 4.76% of portfolio
3,125,000
Q4 2023 Added 15.74%
$219B
$340 Million 4.54% of portfolio
2,000,000
Q3 2022 Reduced 4.76%
$236B
$319 Million 4.26% of portfolio
6,000,000
Q2 2022 Reduced 7.69%
$1.06T
$301 Million 4.02% of portfolio
1,800,000
Q4 2023 Reduced 10.0%
$1.03T
$299 Million 3.99% of portfolio
1,800,000
Q4 2023 Reduced 10.0%
$41.9B
$297 Million 3.96% of portfolio
4,500,000
Q3 2024 Added 9.76%
$498B
$274 Million 3.66% of portfolio
555,000
Q3 2022 Added 38.75%
$403B
$259 Million 3.46% of portfolio
1,600,000
Q2 2024 Reduced 5.88%
$5.48B
$41.3 Million 0.55% of portfolio
858,430
Q3 2024 New
Maplebear Inc
-
$0 0.0% of portfolio
-
Q3 2023 New
Linde PLC
-
$0 0.0% of portfolio
-
Q1 2023 New
Neumora Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q4 2023 Reduced -0.0%

Summary

  • Portfolio
  • No. of Stocks 22
  • Current Value $7.49 Billion
  • Prior Value $7.18 Billion
  • Filing
  • Period Q3 2024
  • Filing Date October 21, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust Portfolio

Follow Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust, based on Form 13F filings with the SEC.

News

Stay updated on Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email